Tag Archives: Lantus®

Sanofi’s investigational therapy Toujeo® consistently showed significantly fewer low blood sugar events compared with Lantus®

Posted on 16, June 2014 by

Meta-analysis of three late-stage trials in people with type 2 diabetes shows decreases in risk of low blood sugar events of up to 31% at night-time compared with Lantus® All studies in the phase 3 “EDITION” clinical trial program, including a … Read the full press release →

Posted in France, Healthcare, Pharma & Biotech

Tagged , , , ,

Sanofi filed patent infringement suit against Eli Lilly over Lantus® and Lantus® SoloStar®

Posted on 31, January 2014 by

Paris, France, 31-1-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it filed a patent infringement suit against Eli Lilly and Company ( “Lilly”) on January 30, 2014 in the United States District Court for the District of Delaware. In … Read the full press release →

Posted in France, Healthcare, Law, Pharma & Biotech

Tagged , , , ,